Subunit-dependent and subunit-independent rules of AMPA receptor trafficking during chemical long-term depression in hippocampal neurons by Shinji Matsuda & Michisuke Yuzaki
国立大学法人電気通信大学 / The University of Electro-Communications
Subunit-dependent and subunit-independent
rules of AMPA receptor trafficking during
chemical long-term depression in hippocampal
neurons
著者（英） Shinji Matsuda, Michisuke Yuzaki
journal or
publication title







Subunit-dependent and independent rules of AMPA receptor trafficking during chemical 
long-term depression in hippocampal neurons 
 
Shinji Matsuda1,2,3, Michisuke Yuzaki3 
 
1Department of Engineering Science, Graduate School of Informatics and Engineering; 2Center for 
Neuroscience and Biomedical Engineering (CNBE), The University of Electro-Communications, 
Tokyo 182-8585, Japan; 3Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, 
Japan 
 
Running Title: AMPA receptor trafficking by GluA1 C-terminus and stargazin 
 
 
To whom correspondence should be addressed: Shinji Matsuda. Department of Engineering Science, 
Graduate School of Informatics and Engineering, The University of Electro-Communications. 1-5-1 
Chofugaoka, Chofu, Tokyo 182-8585, Japan. Phone: +81-42-443-5496. e-mail: smatsuda@uec.ac.jp 
or  
Michisuke Yuzaki. Department of Physiology, Keio University School of Medicine, 35 Shinano-machi, 
Shinjuku-ku, Tokyo 160-8582, Japan. Phone: +81-3-5363-3748; fax: +81-3-3359-0437. e-mail: 
myuzaki@keio.jp 
 
Keywords: AMPA, adaptor protein, endocytosis, ionotropic glutamate receptor, LTP, LTD, neuron, 





Long-term potentiation (LTP) and depression 
(LTD) of excitatory neurotransmission are believed 
to be the neuronal basis of learning and memory. 
Both processes are primarily mediated by neuronal 
activity-induced transport of postsynaptic AMPA-
type glutamate receptors (AMPARs). While 
AMPAR subunits and their specific 
phosphorylation sites mediate differential AMPAR 
trafficking, LTP and LTD could also occur in a 
subunit-independent manner. Thus, it remains 
unclear whether and how, certain AMPAR subunits 
with phosphorylation sites are preferentially 
recruited to or removed from synapses during LTP 
and LTD. Using immunoblot and 
immunocytochemical analysis, we show that 
phosphomimetic mutations of the membrane-
proximal region (MPR), in GluA1 AMPAR 
subunits affects the subunit-dependent endosomal 
transport of AMPARs during chemical LTD. AP-2 
and AP-3, adaptor protein complexes necessary for 
clathrin-mediated endocytosis and late 
endosomal/lysosomal trafficking, respectively, are 
reported to be recruited to AMPARs by binding to 
the AMPAR auxiliary subunit, stargazin (STG), in 
an AMPAR subunit-independent manner. However, 
the association of AP-3, but not AP-2, with STG 
was indirectly inhibited by the phosphomimetic 
mutation in the MPR of GluA1. Thus, although 
AMPARs containing the phosphomimetic mutation 
at the MPR of GluA1 were endocytosed by a 
chemical LTD-inducing stimulus, they were 
quickly recycled back to the cell surface in 
hippocampal neurons. These results could explain 
how the phosphorylation status of GluA1-MPR 
plays a dominant role in subunit-independent STG-




Long-term potentiation (LTP) and long-term 
depression (LTD) of excitatory neurotransmission 
at glutamatergic synapses have been intensively 
studied as the neural basis of learning and memory 
(1,2). LTP and LTD are mainly caused by changes 
in the number of postsynaptic AMPA-type 
glutamate receptors (AMPARs) through activity-
dependent lateral diffusion of AMPARs from or to 
postsynaptic sites, coupled with endosomal 
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transport of AMPARs by exocytosis or endocytosis 
(3,4). GluA1 and GluA4 AMPAR subunits are 
primarily recruited to synapses in an activity-
dependent manner (5,6) during LTP. In contrast, N-
methyl-d-aspartate receptor (NMDAR) activation 
was shown to preferentially induce endocytosis of 
GluA2-containing AMPARs, followed by 
subsequent transport to the late 
endosome/lysosome pathway during LTD (7). In 
contrast, GluA2-lacking AMPARs are recycled 
back to the cell surface (7). Indeed, LTD is impaired 
in the cerebellum lacking GluA2 expression (8). 
Furthermore, phosphorylation of the GluA1 C-
terminus by calcium/calmodulin-dependent protein 
kinase II (CaMKII; Ser831) and protein kinase A 
(PKA; Ser845) have been shown to regulate LTP 
and LTD (9,10). Phosphorylation at Ser818 by 
protein kinase C (PKC) and phosphomimetic 
mutation at Ser816 were shown to promote synaptic 
incorporation of GluA1 (11,12) (Figure 1A). These 
findings indicate that activity-dependent AMPAR 
trafficking is determined by the C-terminus of GluA 
subunits. However, such subunit-specific “rules” 
have been challenged by recent findings that LTP 
(13) and LTD (14) do not require the C-termini of 
GluA subunits. 
   An alternative hypothesis is that AMPAR 
trafficking is regulated by its auxiliary subunits, 
such as transmembrane AMPAR regulatory 
proteins (TARPs), which bind to all AMPAR 
subunits indiscriminately. The C termini of TARPs 
stabilize postsynaptic AMPARs by binding to 
anchoring proteins, such as postsynaptic density 95 
(PSD95) (15). The C-terminus of TARPs, such as -
2 (stargazin, STG), -3, and -8, contain multiple 
conserved phosphorylation sites for CaMKII, PKC, 
and PKA, and positively charged residues (16). 
Phosphorylation of the C-termini of STG is 
required for hippocampal LTP by enhancing its 
binding to PSD95 (17). Conversely, the C-terminal 
of STG is dephosphorylated by various chemical 
LTD induction protocols in cultured hippocampal 
(16,18) and cerebellar (19) neurons. Furthermore, 
dephosphorylation of STG is required for 
NMDAR-dependent hippocampal LTD (16,18) and 
mGluR1-dependent cerebellar LTD (19) in slice 
preparations. We previously showed that 
dephosphorylated TARPs specifically interacted 
with the µ subunit of the adaptor proteins AP-2 (µ2) 
and AP-3 (µ3), which are essential for clathrin-
dependent endocytosis and late 
endosomal/lysosomal trafficking, respectively (18). 
Thus, activity-dependent phosphorylation status of 
TARPs during LTP/LTD could affect lateral 
diffusion of postsynaptic AMPARs, followed by 
their endocytosis, in a manner independent of 
AMPAR subunits. 
   Recently, using mouse lines in which the 
endogenous C-termini of GluA1 and GluA2 were 
replaced with each other, the C-termini of GluA1 
and GluA2 were shown to be necessary and 
sufficient for hippocampal LTP and LTD, 
respectively (20). Thus, we hypothesized that 
AMPAR subunits and their phosphorylation status 
were mechanistically linked with TARP-mediated 
trafficking. In the present study, we examined 
whether and how the phosphorylation of GluA1 C-
terminus could affect its association with STG, a 
prototype of TARP, and adaptor proteins AP-2 and 
AP-3. We show that although the PKC 
phosphorylation sites of GluA1 do not affect its 
interaction with STG, phosphorylation of 
GluA1indirectly inhibits AP-3 binding to STG. 
Unless GluA1 was fully dephosphorylated, 
NMDA-induced LTD was impaired in hippocampal 
neurons, indicating that TARP-mediated AMPAR 




Phosphomimetic mutations of GluA1-MPR 
affects AP-3 binding to STG 
The C-terminus of GluA1, but not GluA2, contains 
three serine residues that can undergo 
phosphorylation by PKC, CaMKII, and PKA (3,21) 
(Figure 1A). To test the hypothesis that the 
phosphorylation status of GluA1 may affect TARP-
mediated AMPAR trafficking, we replaced all four 
serine residues with aspartate (GluA1DDDD) and 
alanine (GluA1AAAA), to mimic phosphorylated and 
dephosphorylated GluA1, respectively. We co-
expressed GluA1 mutants, STG, and FLAG-tagged 
µ2 or µ3 subunits in human embryonic kidney 293 
(HEK293) cells and performed co-
immunoprecipitation assays (Figure 1B). Anti-
GluA1 antibody similarly immunoprecipitated 
GluA1DDDD and GluA1AAAA (Figures 1C and D). 
Although GluA1DDDD and GluA1AAAA similarly co-
immunoprecipitated STG, the amount of µ3, but not 
µ2, that co-immunoprecipitated with GluA1DDDD 
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was lower than that with GluA1AAAA (Figures 1C 
and D). Pre-immune IgG did not 
immunoprecipitate GluA1, STG, 2, or 3 (Figure 
S1). To determine the serine residues responsible, 
we generated GluA1AADD and GluA1DDAA, in which 
either Ser816/Ser818 or Ser831/Ser845 were 
replaced with alanine or aspartate without changing 
the total number of phosphomimetic sites (Figure 
1A). The anti-GluA1 antibody immunoprecipitated 
GluA1AADD and GluA1DDAA similarly. Although 
GluA1AADD and GluA1DDAA similarly co-
immunoprecipitated STG, the amount of µ3 that 
was co-immunoprecipitated by GluA1DDAA was 
lower than that by GluA1AADD (Figure 1E), 
indicating that phosphorylation at Ser816/Ser818 
likely reduced the interaction of STG with µ3. 
Indeed, GluA1DD, in which Ser816/Ser818 was 
replaced with aspartate, co-immunoprecipitated a 
significantly smaller amount of µ3 than GluA1AA, 
in which Ser816/Ser818 were replaced with alanine 
(Figure 1F; p = 0.008, n = 5, by Mann-Whitney U-
test). These results indicate that phosphorylation at 
the membrane-proximal region (MPR) of GluA1 
(Figure 1A) affects AP-3 binding to the AMPAR-
STG complex. 
 
GluA1-MPR enhances the interaction between 
STG and AP-3 
To assess how the MPR of GluA1 affects 
interaction of µ3 with STG, we prepared the C-
terminus of STG as a glutathione S-transferase 
(GST) fusion protein and performed pull-down 
assays using cell lysates of HEK293 cells 
expressing FLAG-tagged µ2 or µ3. We synthesized 
the MPR peptide mimicking phosphorylated 
(MPRDD) or un-phosphorylated (MPRAA) GluA1 
and added it to the lysate at a concentration of 
500M (Figure 2A). The presence of MPRAA or 
MPRDD did not affect the amount of µ2 pulled-
down by GST-STG (Figure 2B; n = 4, p = 0.99 by 
Kruskal-Wallis test). There was no difference in the 
amount of precipitated GST-STG; however, the 
amount of µ3 pulled down by GST-STG was 
significantly increased by addition of the MPRAA 
peptide (Figure 2C; MPRAA, 126 ± 18%; MPRDD, 
100 %; without MPR, 86 ± 13%; p = 0.006, MPRAA 
vs. MPRDD; p = 0.043, MPRAA vs. −MPR, n = 6 
each, by Kruskal-Wallis test and Steel-Dwass post 
hoc test). These results indicate that the presence of 
unphosphorylated MPR of GluA1 selectively 
enhanced the interaction between STG and AP-3. 
   STG itself contains multiple positively charged 
residues and phosphorylation sites at the C-
terminus (Figure 2A). We next examined whether 
the facilitatory effect of MPRAA on STG-AP-3 
interaction was affected by the phosphorylation 
status of STG. As reported previously, the amount 
of µ3 pulled down by GST-STG9D, in which nine 
serine residues were replaced with aspartate to 
mimic phosphorylated STG, was significantly 
lower than that pulled down by GST-STG9A, 
mimicking the unphosphorylated form (Figure 2D; 
STG9A, 100%; STG9D, 21 ± 3%; p = 0.002, n = 6 
each, by Mann-Whitney U-test). The presence of 
MPRAA or MPRDD did not affect the amount of µ3 
pulled down by STG9D (Figure 2D; p = 0.48 
Kruskal-Wallis test). In contrast, the amount of µ3 
pulled down by STG9A was significantly increased 
by the addition of MPRAA (Figure 2E). These 
results indicate that the interaction between STG 
and µ3 is favored when the STG is 
unphosphorylated and that the presence of 
unphosphorylated GluA1-MPR further enhances 
STG-µ3 association. 
     
GluA1-MPR directly binds STG and indirectly 
enhances STG-AP3 interaction 
To examine whether and how the MPR of GluA1 
binds to the C-terminus of STG, we synthesized 
biotinylated MPRDD and MPRAA and performed a 
pull-down assay using streptavidin beads (Figure 
3A). GluA1-MPRAA pulled down GST-STG much 
more than MPRDD (Figure 3B). To identify the 
region of STG necessary for MPR binding, we 
prepared GST-STGCT1 and GST-STGCT12, in which 
the C-terminus of STG was sequentially deleted 
(Figure 3C). Although STGwt and STGCT12 were 
similarly pulled down by GluA1-MPRAA, STGCT1 
was not (Figure 3D), indicating that the CT2 region 
(230–259) was mediating binding to the MPR of 
GluA1. When the cell lysates from HEK293 cells 
expressing FLAG-tagged µ3, were pulled down by 
biotinylated MPRAA in the presence of GST or 
GST-STGwt (Figure 3A), a large amount of µ3 was 
pulled down by MPRAA in the presence of GST-
STGwt compared with GST (Figure 3E; GST only, 
100%; GST-STGwt, 180 ± 34%; p = 0.0003, n = 8, 
by Mann-Whitney U test), indicating that µ3 
indirectly associates with the STG-MPR complex. 
Together, we propose that dephosphorylated STG 
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directly binds to AP-3, and that dephosphorylated 
GluA1-MPR could further bind to STG and 
indirectly enhance the GluA1-STG complex 
(Figure 3F). 
 
Phosphomimetic mutations of GluA1-MPR 
regulates NMDA- induced LTD 
To clarify the role of phosphorylation of GluA1-
MPR on AMPAR trafficking, we used a chemical 
LTD model, in which NMDA application induces 
AMPAR endocytosis (7,18). We expressed mutant 
GluA1, in which a hemagglutinin (HA) tag was 
added to the N-terminal extracellular domain, and 
Ser816/Ser818 were replaced with aspartate 
(GluA1DD) or alanine (GluA1AA), in cultured 
hippocampal neurons. After treatment with NMDA 
(50 µM) for 10 min, the cell surface and total 
GluA1 were sequentially detected by an anti-HA 
antibody before and after permeabilizing the 
plasma membrane (Figures 4A, C and E). 
Mutations in the MPR did not affect the total and 
surface expression levels of GluA1 at the basal state 
(Figure S2). NMDA treatment reduced the intensity 
of cell surface HA-GluA1wt (Figures 4A and B; p = 
0.0006, n = 8-9 cells) and HA-GluA1AA (Figures 4C 
and D; p = 0.03, n = 13-14 cells, by two-tailed 
Student’s t test). In contrast, the intensity of cell 
surface HA-GluA1DD was not affected by the 
NMDA treatment (Figures 4E and F; p = 0.53, n = 
12-13 cells, by two-tailed Student’s t test). These 
results indicate that phosphorylation of GluA1-
MPR inhibits NMDA-induced AMPAR 
endocytosis during chemical LTD. 
 
Phosphomimetic mutations of GluA1-MPR 
regulates trafficking to the late 
endosome/lysosome 
The number of cell-surface AMPARs is determined 
by the balance between endocytosis and exocytosis. 
To clarify the effect of phosphorylation of GluA1-
MPR on AMPAR trafficking, we performed an 
antibody feeding assay (18) (Figure 5A). HA-
GluA1 on the cell surface of living neurons was 
first labeled with an anti-HA antibody and NMDA 
was applied to the neurons to induce AMPAR 
endocytosis. After removal of the anti-HA antibody 
remaining on the cell surface by acid treatment, the 
population of HA-GluA1 that was endocytosed by 
the NMDA treatment and recycled to the cell 
surface within 30 min was specifically visualized. 
The antibody feeding assay indicated that the 
amount of recycled HA-GluA1DD was significantly 
larger than that of HA-GluA1wt and HA-GluA1AA 
(Figures 5B and C; HA-GluA1wt, 100 ± 19%; HA-
GluA1AA, 128 ± 12%; HA-GluA1DD, 197 ± 24%; p 
= 0.003, HA-GluA1wt vs. HA-GluA1DD; p = 0.015, 
HA-GluA1AA vs. HA-GluA1DD; n = 12 cells each, 
by one way ANOVA and Student-Newman-Keuls 
post hoc test). These results indicate that although 
HA-GluA1DD was endocytosed in response to 
NMDA treatment, it was recycled back to the cell 
surface.   
   To gain mechanistic insight into how 
phosphorylation of GluA1-MPR affects AMPAR 
trafficking, we co-expressed HA-GluA1wt, HA-
GluA1AA, or HA-GluA1DD with EGFP-tagged Rab4 
to label early endosomes in hippocampal neurons. 
We also used EGFP-Rab7 to detect late endosomes 
or/and lysosomes and immunostained MAP2 to 
identify dendrites. HA- GluA1wt and HA-GluA1AA 
immunoreactivities were co-localized with Rab4 at 
3 min, and Rab7 at 10 min along dendrites after 
NMDA treatment (Figures 6A and B). In contrast, 
although HA-GluA1DD immunoreactivity was co-
localized with Rab4 at 3 min, it did not overlap with 
Rab7 at 10 min after NMDA treatment (Figure 6A 
and B). Quantitative analysis indicated that HA-
GluA1wt, HA-GluA1DD and HA-GluA1AA were 
similarly co-localized with Rab4 at 3 min after 
NMDA treatment (Figure 6C; n = 9−12 cells, p = 
0.95 by Kruskal-Wallis test). In addition, HA-
GluA1DD showed significantly lower levels of co-
localization with Rab7 than HA-GluA1wt and HA-
GluA1AA at 10 min after NMDA treatment (Figure 
6D; p = 0.021, HA-GluA1wt vs. HA-GluA1DD; p = 
0.001, HA-GluA1AA vs. HA-GluA1DD; n = 10−12 
cells each, by Kruskal-Wallis test and Steel-Dwass 
post hoc test). These results indicate that 
phosphorylation of GluA1-MPR regulates NMDA-
induced AMPAR endocytosis by controlling the 
transport of AMPARs from early endosomes to late 
endosomes/lysosomes. 
 
Interaction among multiple phosphorylation sites 
at the GluA1 C-terminus 
The necessity of PKC phosphorylation at 
Ser816/Ser818 for LTP expression was 
demonstrated by enhancing 4.1N binding to GluA1 
(12). We immunoprecipitated endogenous 4.1N 
from the cell lysate of cultured hippocampal 
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neurons to examine whether chemical LTD 
stimulation affected the interaction between 4.1N 
and GluA1. We found that the amount of GluA1 
coimmunoprecipitated by 4.1N was significantly 
reduced following NMDA treatment (Figure 7A; n 
= 5, p = 0.008, by Mann-Whitney U test), whereas 
pre-immune IgG did not precipitate GluA1 or 4.1N 
(Figure S1C). These results suggest that GluA1 is 
dephosphorylated at Ser816/Ser818 by chemical 
LTD induction, and its reduced binding to 4.1N 
may also contribute to stable LTD expression by 
reducing reinsertion of AMPARs. 
   Phosphorylation of GluA1 at Ser831 and Ser845 
has been shown to regulate LTP and LTD (9,10). To 
examine whether the phosphomimetic or phospho-
deficient mutations of GluA1 MPR affected the 
phosphorylation at Ser831 and 845, we carried out 
an in vitro phosphorylation assay using GST-fused 
GluA1 C-termini. We found that GST fused with 
the C-termini of wild-type GluA1 (GluA1wt), 
phospho-deficient GluA1AA, and phosphomimetic 
GluA1DD were phosphorylated similarly by 
CaMKII at Ser831 (Figure 7B), and by PKA at 
Ser845 (Figure 7C). Thus, phosphorylation at 
Ser831/Ser845 is unlikely to be affected by 
phosphorylation at the MPR, indicating that the 
effect of Ser816/Ser818 on GluA1 trafficking is 
independent of the phosphorylation status of Ser 
831/Ser845. 
 
GluA1-MPR regulates heteromeric AMPAR 
trafficking 
Endogenous AMPARs mainly exist as 
diheteromeric GluA1-GluA2 and GluA2-GluA3 
receptors in the mammalian brain (22,23). Next, we 
expressed HA-tagged GluA2 and untagged 
GluA1wt, GluA1DD, or GluA1AA in cultured 
hippocampal neurons to examine whether the 
phosphorylation of GluA1-MPR affects the 
trafficking of heteromeric AMPARs composed of 
GluA1 and GluA2. After treatment with NMDA (50 
µM) for 10 min, the cell surface and total GluA2 
were sequentially detected by an anti-HA antibody 
before and after permeabilizing the plasma 
membrane. Mutations in the GluA1 MPR did not 
affect the total and surface expression levels of HA-
GluA2 during the basal state (Figure S3). The 
intensity of cell surface HA-GluA2 
immunoreactivity was significantly reduced by the 
NMDA treatment in neurons co-expressing 
GluA1wt (Figures 8A and B;  control, 100 ± 14%; 
NMDA, 67 ± 8%; p = 0.045, n = 11-12 cells each), 
as well as neurons co-expressing GluA1AA (Figures 
8C and D;  control, 100 ± 3%; NMDA, 83 ± 4%; p 
= 0.002, n = 16-19 cells each), but not in neurons 
co-expressing GluA1DD (Figures 8E and F;  control, 
100 ± 4%; NMDA, 112 ± 5%; n = 15 cells each, p 
= 0.07, by two-tailed Student’s t-test). Since cell-
surface HA-GluA2 likely exists in the form of 
heteromeric receptors with GluA1, these results 
indicate that the phosphorylation status at the MPR 
of GluA1 dominantly affects heteromeric AMPAR 




It has been unclear whether and how subunit-
specific rules of AMPAR trafficking are related to 
subunit-independent, TARP-mediated AMPAR 
trafficking mechanisms during LTP/LTD. In the 
present study, we showed that phosphomimetic 
mutations of GluA1-MPR inhibited AP-3 binding 
to STG and late endosomal/lysosomal trafficking of 
AMPARs, which is required for LTD expression 
(7,24). Thus, together with earlier findings, we 
propose a model in which STG-dependent and 
GluA1-MPR-dependent AMPAR trafficking 
mechanisms interact with each other during LTD in 
hippocampal neurons (Figure 9). At postsynaptic 
sites, AMPARs are stabilized by anchoring proteins, 
such as PSD-95, which bind to highly 
phosphorylated STG (17). NMDAR activation 
induces dephosphorylation of STG (16,18), 
releasing the anchor so that the AMPAR-STG 
complex laterally diffuses to the endocytic zones. 
At the endocytic zone, AP-2 accumulates (25) and 
binds to dephosphorylated STG to induce clathrin-
mediated endocytosis of the AMPAR-STG 
complex. In the early endosome, AP-2 is replaced 
with AP-3 to mediate transport to the late 
endosomes/lysosomes (Figure 9A). When an 
AMPAR contains GluA1, in which the MPR 
remains phosphorylated, AP-3 cannot associate 
with STG and the AMPAR-STG complex is 
recycled back to the cell surface by interacting with 
4.1N (11,12) (Figure 9B). 
   While -8 is the dominant TARP in CA1 
pyramidal neurons, -3 and STG are also modestly 
expressed (26). Since these TARPs contain 
conserved serine residues at the C-termini that 
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undergo phosphorylation (16), the inhibitory effect 
of STG mutants on hippocampal LTD may be 
mediated by the dominant-negative effect of STG. 
Similarly, normal LTD in -8 knockout mice (27) 
may be caused by compensation by the other 
TARPs (28). Alternatively, STG may play a 
specific role in the regulation of LTD in CA1 
hippocampal neurons since it is highly enriched at 
perforated synapses (28), which are thought to play 
an important role in LTD induction (29).  
 
       
Hierarchy of AMPAR trafficking mediated by 
GluA subunits and phosphorylation 
Although AMPAR subunits and posttranslational 
modifications determine the types and extent of 
synaptic plasticity, a hierarchy may exist such that 
certain AMPARs are disproportionally recruited to 
or removed from synapses during LTP and LTD (3). 
This hierarchy hypothesis explains why LTP (13) 
and LTD (14) could still be induced in a manner 
independent of AMPAR subunits. However, it 
remains unclear how a hierarchy is determined by 
the subunit-dependent phosphorylation of 
AMPARs. We postulate that phosphorylation of 
GluA subunits affects two steps in AMPAR 
trafficking: anchoring at postsynaptic sites and 
endocytosis or exocytosis to or from plasma 
membranes. 
   For LTD, GluA2 has shown to play a major role 
in the hierarchy of AMPAR endocytosis in many 
brain regions (3). Specifically, phosphorylation of 
GluA2 Ser880 regulates LTD in the cerebellum (8) 
and the hippocampus (30). This effect is likely 
explained by the anchoring of GluA2-containing 
AMPARs by GRIP1/2 and PICK1 (31,32). 
Phosphorylation at Ser880 by PKC releases GluA2 
from the GRIP1/2 anchor during cerebellar LTD 
(33,34). However, surface AMPARs are tightly 
associated with TARP, through which the AMPAR-
TARP complex is anchored to postsynaptic sites. 
Thus, the release from GRIP could not fully explain 
the dominant role of GluA2 during LTD.   
   At the endocytic zone, AMPARs need to be 
recognized by AP-2 for clathrin-dependent 
endocytosis. Although the MPR of GluA2 was 
shown to bind to the µ2 subunit of AP-2 (35), µ2 is 
mainly recruited to AMPARs by binding to 
dephosphorylated STG in a manner independent of 
GluA subunits (18) and their phosphorylation status 
(Figure 1). GluA2, in which Ser880 is 
phosphorylated, could bind to PICK1 at the 
endocytic zone, which has been shown to recruit the 
 subunit of AP-2 and dynamin (36). Thus, the 
dominant role of GluA2 in LTD could be partly 
attributed to its preferential binding to PICK1. 
   After endocytosis, AMPARs need to be trafficked 
to late endosomes/lysosomes for LTD expression 
(7,24). Unlike µ2, the µ3 subunit of AP-3 could not 
be recruited to STG unless the MPR of GluA1 was 
fully dephosphorylated (Figure 8 B). Thus, the 
absence of phosphorylation sites at the MPR of 
GluA2 (Figure 1 A) could also contribute to the 
preferential role of GluA2-containing and GluA1-
lacking AMPARs in LTD expression.  
   Phosphorylation of the MPR of GluA1 by PKC 
was previously shown to promote synaptic 
incorporation of AMPARs during LTP (11,12). 
Similarly, GluA1, which contained 
phosphomimetic mutations in the MPR, was 
recycled from the endosome to the cell surface 
(Figure 5). Because AMPARs are reported to be 
exocytosed from recycling endosomes (37), 
phosphorylation-dependent binding to µ3 by the 
MPR of GluA1 may also explain the subunit-
selective hierarchy in LTP expression. 
 
Towards a unified theory of AMPAR trafficking 
There remain many questions about how other 
phosphorylation sites of GluA subunits affect the 
hierarchy of AMPAR trafficking. For example, 
although phosphorylation at Ser845 of GluA1 is 
required for LTD induction (9,10), the mechanisms 
by which such subunit-specific phosphorylation 
affects LTD is achieved, remain unclear. Recently, 
phosphorylation at Ser845 was shown to transiently 
recruit GluA1-containing, Ca2+-permeable 
AMPARs, to postsynaptic sites to fully activate 
calcineurin during LTD (38). Indeed, calcineurin is 
absolutely required to dephosphorylate TARP to 
release the AMPAR-TARP complex from the 
postsynaptic anchor during hippocampal and 
cerebellar LTD (16,19). However, it is unclear how 
phosphorylation at Ser845 mediates preferential 
trafficking of GluA1 to postsynaptic sites. Similarly, 
the mechanisms by which phosphorylation at 
Ser831 of GluA1 contribute to LTP, remain unclear. 
Although phosphomimetic and phospho-deficient 
mutations at the MPR did not affect the 
phosphorylation at Ser831/Ser845 (Figures 8B and 
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C), phosphorylation at Ser831/Ser845 was shown 
to work in concert with Ser818 phosphorylation to 
trigger the stable incorporation of GluA1 during 
hippocampal LTP (11). Thus, the effect of 
phosphorylation at Ser831 and Ser845 on AMPAR 
trafficking could be partly attributed to 
phosphorylation levels at the MPR, which 
determine the association with AP-3 and 4.1N. 
   In addition to regulating AMPAR trafficking, 
phosphorylation of the GluA1 C-termini may 
contribute to LTP/LTD by regulating the channel 
conductance and the heteromeric assembly of 
AMPARs. Since the phosphomimetic and 
phospho-deficient mutations at Ser818 
similarly prevented AKAP79-induced increase 
in GluA1 homomers (39), this effect will not be 
involved in GluA1 phosphomimetic status-
dependent AMPAR trafficking during LTD. On 
the other hand, PKC phosphorylation at Ser818 
increases the channel conductance of AMPARs (40). 
Thus, the dephosphorylation at Ser818 may 
enhance LTD induction by decreasing the channel 
conductance of the synaptic AMPA receptors in 
addition to the reduction in the number of cell-
surface AMPA receptors. 
   Because differential phosphorylation of AMPARs 
is reported in certain mouse models of 
neuropsychiatric disease, such as fragile X mental 
retardation (41), further studies are warranted to 
clarify the molecular mechanisms by which 
phosphorylation and other posttranslational 






All procedures related to animal care and treatment 
were performed in accordance with the guidelines 
approved by the animal resource committees of the 
University of Electro-communications and Keio 
University. Mice were housed with a 12:12 h light-
dark cycle with food and water available ad libitum. 
 
Chemicals and Antibodies 
NMDA was purchased from Tocris Bioscience. 
Commercial antibodies: anti-GluA1 (Millipore 04-
855), anti-GluA1 (Sigma SAB5201086), anti 
phospho-GluA1 (Ser831) (Invitrogen 36-8200), 
anti-phospho-GluA1 (Ser845) (Invitrogen 36-
8300), anti-stargazin (Sigma C8206), anti-4.1N 
(Synaptic Systems 276 103), anti-GST (Amersham 
RPN1236), anti-HA, (Covance 901501), anti-
FLAG (Sigma F7425), and anti-MAP-2 (Millipore 
AB5622) antibodies; Alexa-350 (Thermo Fisher A-
11045), 405 (Thermo Fisher A-31556), 488 
(Thermo Fisher A-11008), 546 (Thermo Fisher A-
11003), HRP (Rockland 18-8816-33, 18-8817-33) 
conjugated secondary antibodies. Pre-immune IgG 
(CYP450-GP HU-A000). 
 
Construction and Transfection or Transformation 
of Expression Plasmids 
Using a PCR method and Pyrobest (Takara), the 
serine residues encoding Ser816, Ser818, Ser831, 
and Ser845 in mouse GluA1 cDNA were mutated 
to encode aspartate or alanine. The cDNA encoding 
HA was added to the 5' end (immediately following 
the signal sequence) of mutant GluA1 and wild-
type GluA2. The cDNA encoding FLAG-tag was 
added to the 3’ end (immediately upstream of the 
stop codon) of mouse µ2 or mouse µ3A cDNAs.  
The nucleotide sequences of the amplified open 
reading frames were confirmed by bidirectional 
sequencing. After the cDNAs were cloned into the 
expression vectors, either pTracer (Invitrogen) or 
pCAGGS (provided by Dr. J Miyazaki, Osaka 
University, Osaka, Japan), the constructs were 
transfected into human embryonic kidney 293T 
(HEK293T) cells using the Ca2+-phosphate method 
or were transfected into cultured hippocampal 
neurons using Lipofectamine 2000 (Invitrogen). 
   For the expression of GST-fusion protein, the 
cDNA encoding the C-terminal region of wild-type 
or mutant TARPs or GluA1 was amplified by PCR 
and cloned into pGEX 4T-2. E. coli. BL21(DE3) 
was transformed by pGEX expression vectors and 
grown in 100 ml of LB medium. The expression of 
GST fusion proteins was induced by the addition of 
IPTG 0.1 mM. BL21(DE3) cells were disrupted by 
sonication in 10 ml of phosphate-buffered saline 
(PBS), and 500l of Glutathione Sepharose 
column (Amersham Pharmacia) suspension was 
added to the supernatant. After washing with 1 ml 
PBS five times, GST fusion proteins were eluted 
with 1 ml of elution buffer (100 mM Tris HCl, 10 
mM glutathione, pH 8.0). 
 
Culture of Hippocampal Neuron 
Hippocampi dissected from E16/17 ICR mice were 
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treated with 10 U ml-1 trypsin and 100 U ml-1 DNase 
in Dulbecco's modified Eagle's medium at 37°C for 
20 min. The dissociated hippocampal neurons were 
plated on polyethyleneimine (PEI)-coated glass 
coverslips and cultured in Neurobasal medium 
(Invitrogen) with B-27 (Gibco) or NS21 
supplement (42) and 0.5 mM L-glutamine. After 7-
10 DIV culture, neurons were transiently 
transfected with plasmids using Lipofectamine 
2000, and used for the AMPA receptor endocytosis 
or recycling assays. 
 
Assay for AMPA receptor Endocytosis 
Hippocampal neurons transfected with pCAGGS 
expression vectors for mutant HA-GluA1 plus GFP 
or wild-type HA-GluA2 plus mutant GluA1 were 
stimulated with 50 µM NMDA for 10 min and fixed 
in 4% paraformaldehyde without permeabilization, 
for 10 min at room temperature. After fixed neurons 
were washed with PBS and incubated with a 
blocking solution (2% BSA and 2% normal goat 
serum in PBS), surface HA-GluA1 or HA-GluA2 
were labeled with the anti-HA antibody (1:1000) 
and visualized with Alexa 546-secondary antibody 
(1:1000). To label total HA-GluA1 or HA-GluA2, 
neurons were permeabilized and blocked with a 
blocking solution containing 0.4% Triton X-100, 
and incubated with the anti-HA antibody (1:1000) 
and Alexa 350-secondary antibodies (1:1000). 
Fluorescence images were captured using a 
fluorescence microscope (BX60, Olympus) 
equipped with a CCD camera (DP 70, Olympus) 
and analyzed using IP-Lab software (Scanalytics). 
For statistical analysis of the surface expression 
level of HA-GluA1 or HA-GluA2, the intensity of 
Alexa 546 for surface HA-GluA1 or HA-GluA2 
was measured and normalized using the intensity of 
Alexa 350 for total HA-GluA1 or HA-GluA2. The 
fluorescence intensity on the dendrites at least 20 
μm away from the soma, was measured. In the 
representative images, brightness and contrast were 
adjusted uniformly within each experimental series 
for consistent visibility. 
 
Assay for AMPA receptor recycling 
Recycling of AMPA receptors was analyzed by the 
method described by Nooh et al. (43). Living 
hippocampal neurons transfected with plasmids for 
mutant HA-GluA1 were labeled with anti-HA 
antibody (1:100) for 1 h. After washing out the 
excess amount of antibody, neurons were 
stimulated with 50 µM NMDA for 3 min. After 
washing out the NMDA, neurons were treated with 
0.5 M NaCl and 0.2 M acetic acid for 4 min at 0°C. 
After washing out NaCl and acetic acid, neurons 
were incubated for 30 min at 37°C in a neurobasal 
medium with B27 supplement. The neurons were 
then fixed in 4% paraformaldehyde without 
permeabilization, for 10 min at room temperature. 
After fixed neurons were washed with PBS and 
incubated in a blocking solution (2% BSA and 2% 
normal goat serum in PBS), surface HA antibody 
was visualized with Alexa 546-secondary antibody 
(1:1000). To label internalized HA-GluA1, neurons 
were permeabilized and blocked with the blocking 
solution containing 0.4% Triton X-100 and 
incubated with the Alexa 350-secondary antibodies 
(1:1000). Fluorescence images were captured by a 
fluorescence microscope equipped with a CCD 
camera and analyzed using IP-Lab software. For 
statistical analysis of the recycled HA-GluA1, the 
intensity of Alexa 546 for recycled HA-GluA1 was 
measured and normalized using the intensity of 
Alexa 350 for internalized HA-tagged GluA1. The 
fluorescence intensity on the dendrites at least 20 
μm away from the soma, was measured.  In the 
representative images, brightness and contrast were 
adjusted uniformly within each experimental series 
for consistent visibility. 
 
Colocalization assay of HA-GluA1 and Rab 
proteins 
Hippocampal neurons transfected with pCAGGS 
expression vectors for mutant HA-GluA1, Rab4, or 
Rab7-EGFP were stimulated with 50 µM NMDA 
for 3 or 10 min and fixed in 4% paraformaldehyde. 
After fixed neurons were washed with PBS and 
incubated with a blocking solution (2% BSA and 
2% normal goat serum 0.4% Triton-X in PBS), the 
neurons were incubated with the anti-HA antibody 
(1:1000) and anti-MAP-2 antibody (1:1000) for 1 h 
at room temperature. After washing with PBS, 
neurons were incubated with Alexa 546- and Alexa 
405-secondary antibodies (1:1000; Invitrogen). 
Fluorescence images were captured using a 
confocal microscope (FV1200, Olympus) and 
analyzed using IP-Lab software (Scanalytics). To 
statistically analyze the colocalization of the HA-
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GluA1 and Rab proteins, the intensities of Alexa 
546 on the EGFP-positive regions were measured 
and normalized using the total intensity of Alexa 
546. The fluorescence intensity on the dendrites at 
least 20 μm away from the soma, was measured.  
In the representative images, brightness and 
contrast were adjusted uniformly within each 
experimental series for consistent visibility. 
 
In vitro phosphorylation of GST-GluA1CT 
Purified GST fusion proteins (20 l) with a GluA1 
C-terminus were subjected to an in vitro 
phosphorylation assay using the CAMK2a Kinase 
Enzyme System and PKA Kinase Enzyme System 
according to the manufacturer’s protocol 
(Promega). Phosphorylated GST fusion proteins 
were analyzed by immunoblot analysis using anti-
Phospho-GluA1 (Ser831), Phospho-GluA1 
(Ser845) (Invitrogen), and anti-GST (Amersham) 
antibodies. 
 
Immunoprecipitation, Pull-Down Assay, and 
Immunoblot Assays 
Transfected HEK293T cells were solubilized in 6-
cm dishes in 500 µL of TNE buffer (50 mM NaCl, 
10 % NP-40, 20 mM EDTA, 0.1 % SDS, 50 mM 
Tris-HCl, pH 8.0) supplemented with a protease 
inhibitor cocktail (Calbiochem). Cultured 
hippocampal neurons (DIV 17) from three wells of 
the 12-well dish (Falcon) were solubilized in 300 
µL of lysis buffer (250 mM NaCl, 1.5% Triton-X, 5 
mM EDTA, 25 mM Tris-HCl, pH 7.4) with a 
protease inhibitor cocktail. Finally, 0.5% of the total 
lysate was applied to the immunoblot analysis as 
the input. 
   For the immunoprecipitation assays, 5 µl of anti-
GluA1 (Millipore) or anti 4.1N (Synaptic Systems) 
or preimmune IgG (CYP450-GP) was added to the 
samples, and the mixture was incubated for 1 h at 
4°C. Then, 50 µL of protein G-conjugated agarose 
(Amersham) was added, and this mixture was 
incubated for 1 h at 4°C. After the precipitates were 
washed four times with 500 µL of TNE buffer or 
lysis buffer, 50 µL of SDS-PAGE sample buffer was 
added and the samples were incubated for 5 min at 
95°C. After centrifugation, 5 µL of the supernatant 
was analyzed using immunoblotting with anti-
FLAG (Sigma), anti GluA1 (Sigma) anti stargazin 
(Sigma), and anti 4.1N (Synaptic Systems) 
antibodies, TrueBlot HRP-conjugated secondary 
antibody (Rockland), and the Immobilon Western 
kit (Millipore). The chemiluminescence signals 
were detected by Luminograph II (ATTO) and 
quantified using CS Analyzer software (ATTO). 
   For GST pull-down assays, purified GST fusion 
proteins (50 l) with a TARP C-terminus were 
incubated with the lysate of HEK293T cells 
expressing the µ subunit of adaptor protein in the 
presence or absence of 500M of peptides 
corresponding to the MPR of AMPA receptors. 
After a 1 h incubation at 4°C, GST proteins were 
pulled down by glutathione sepharose resins 
(Amersham). 50 µL of SDS-PAGE sample buffer 
was added to the precipitates and the samples were 
incubated for 5 min at 95°C. After centrifugation, 5 
µL of the supernatant was analyzed by immunoblot 
analysis with anti-FLAG (Sigma) and anti GST 
(Amersham) antibodies. 
   For the biotinylated peptide (EFCYKSRSES 
KRMK) pull-down assay of GST fusion proteins, 
50 l of purified GST fusion proteins with a TARP 
C-terminus were incubated with the biotinylated 
peptide corresponding to the MPR of AMPA 
receptors (500 M) in 500l of PBS. For the 
biotinylated peptide pull down assay of FLAG-3, 
HEK293 cells expressing FLAG 3 were 
solubilized in 500 l TNE and 500 M biotinylated 
peptide were added together with 5 g of GST or 
GST-STG fusion proteins. After incubation at 4°C 
for 1 h, biotinylated peptides were pulled down 
using 50 l of streptavidin-conjugated magnetic 
beads (Invitrogen), and the precipitates were 
analyzed by immunoblot analysis.  
 In the representative images, brightness and 
contrast were adjusted uniformly within each 
experimental series for consistent visibility. 
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Figure 1. Phosphomimetic mutations of MPR regulate the affinity of the AMPA receptor-TARP 
complex to AP-3. A. Amino acid sequences of the C-terminus of AMPAR subunits and GluA1 
mutants. Serine residues that can be phosphorylated by PKC, CaMKII, and PKA are indicated. 
These residues were replaced with aspartate and alanine to mimic phosphorylation (blue) and 
dephosphorylation (red). Although Ser816 is not directly phosphorylated, it enhances the effect 
of the Ser818 mutation. B. Schematic drawing of the co-immunoprecipitation assay. Lysates of 
HEK293 cells expressing STG, GluA1 mutants, and FLAG-tagged µ2 or µ3 were 
immunoprecipitated using the anti-GluA1 antibody. C, D. The effect of mutation of all serine 
residues of GluA1 on the interaction with µ2 or µ3. While µ2 was similarly co-
immunoprecipitated with GluA1AAAA and GluA1DDDD (C), µ3 was preferentially co-
immunoprecipitated with GluA1AAAA than GluA1DDDD (D). Top: The intensity of the band 
corresponding to µ2 or µ3 that was co-immunoprecipitated was normalized to the intensity of the 
respective molecule in the input lysate. Data are presented as mean + SEM and individual data 
points (yellow circles) (Mann-Whitney U test, *p < 0.05; n = 4). Bottom: The intensity of the 
band corresponding to GluA1 (left) or STG (right) co-immunoprecipitated was normalized to the 
intensity of the respective molecule in the input lysate. Data are presented as mean + SEM and 
individual data points. E. The effect of the position of the mutations on the interaction with µ3. 
µ3 was preferentially co-immunoprecipitated with GluA1AADD than with GluA1DDAA. The 
intensity of µ3 in the immunoprecipitated fraction was normalized to that of the input lysate. Data 
are presented as mean + SEM and individual data points (Mann-Whitney U-test, *p < 0.05; n = 
6). F. The effect of mutations in the MPR on the interaction with µ3. µ3 was preferentially co-
immunoprecipitated with GluA1AA than with GluA1DD. The intensity of µ3 in the 
immunoprecipitated fraction was normalized to that of the input lysate. Data are presented as 
mean + SEM and individual data points (Mann-Whitney U-test, **p < 0.01; n = 5). 
 
Figure 2. Phospho-deficient MPR enhances the interaction between STG and AP-3. A. 
Schematic drawing of the pull-down assay. Lysates of HEK293 cells expressing FLAG-tagged 
µ2 or µ3 were pulled down with the GST-fused C-terminus of STG (GST-CT) in the presence or 
absence of synthetic peptides corresponding to the MPR of GluA1. Amino acid sequences of the 
MPR and STG-CT, in which serine residues were replaced with alanine (red) or aspartate (blue) 
to mimic phosphorylated and dephosphorylated forms, are shown. B, C. Pull-down assays 
showing the effect of MPR on the interaction between wild-type STG and µ2 or µ3. Top:  The 
amount of µ2 or µ3 that was pulled down with GST-STGwt in the presence of MPRDD was 
arbitrarily established as 100%. The addition of MPRDD or MPRAA did not affect the interaction 
between STGwt and µ2 (B), whereas MPRAA enhanced the interaction between STGwt and µ3 
(C). Data are presented as mean + SEM and individual data points. Kruskal-Wallis test and 
Steel-Dwass post hoc test, *p < 0.05; n = 6 each. Bottom: The graphs indicate the amount of 
pulled down GST-STG. The amount of GST-STG in the pulled-down fraction with MPRDD was 
arbitrarily established as 100%. D. Pull-down assays showing the effect of MPR on the 
interaction between µ3 and STG9A or STG9D. The amount of µ3 that was pulled down with 
GST-STG9A without the addition of MPR was arbitrarily established as 100%. Phosphomimetic 
mutation of STG (STG9D) significantly reduced the amount of pulled down µ3. Data are 
presented as mean + SEM and individual data points. Mann-Whitney U-test, **p < 0.01; n = 6 
each. The MPR peptides did not affect the interaction between µ3 and STG9D. Kruskal-Wallis 
test and Steel-Dwass post hoc test, n = 6 each. E. Pull-down assays showing the effect of MPR 
on the interaction between STG9A and µ3. The amount of µ3 that pulled down with GST-STG9A 
in the presence of MPRDD was arbitrarily established as 100%. The addition of MPRAA 
enhanced the interaction between STG9A and µ3. Data are presented as mean + SEM and 
individual data points. Kruskal-Wallis test and Steel-Dwass post hoc test, **p < 0.01, *p < 0.05; 
n = 6 each. 
 
AMPA receptor trafficking by GluA1 C-terminus and stargazin 
 16
Figure 3. Phospho-deficient MPR directly binds to the C-terminus of STG. A. Schematic 
drawing of the pull-down assay. GST-fused C-terminus of STG (STG-CT) was pulled down 
using avidin that interacted with a synthetic biotinylated MPR peptide. In some experiments, 
lysates of HEK293 cells expressing FLAG-tagged µ3 were added. B. Pull-down assays showing 
a direct interaction between STG-CT and MPR. Phospho-deficient MPR (MPRAA) showed a 
stronger interaction with STG-CT than phosphomimetic MPR (MPRDD). C. Schematic drawing 
of the deletion mutants of the GST-fused C-terminus of STG. Lower numbers indicate the 
amino acid position of full-length STG. D. Pull-down assays showing the interaction between 
STG deletion mutants and GluA1-MPR. The amount of STG pulled down with GluA1-MPRAA 
was reduced by the deletion of amino acids 229–259 (STGCT1). E. Pull-down assays showing 
GluA1-MPR indirectly associates with µ3 via STG. A larger amount of µ3 was pulled down by 
GluA-MPRAA when lysates of HEK293 cells expressing FLAG-tagged µ3 were added. The 
amount of µ3 pulled down with MPRAA in the presence of GST was arbitrary established as 
100%. Data are presented as mean + SEM and individual data points. Mann-Whitney U-test, 
**p < 0.01; n = 8. F. Schematic drawing of the enhanced interaction between STG and AP-3 by 
addition of dephosphorylated MPR. Dephosphorylated STG can interact with AP-3, and this 
interaction is further enhanced by the binding of dephosphorylated GluA1-MPR to the CT2 
region of STG. 
 
Figure 4. MPR regulates NMDA-induced AMPAR internalization. A, C, E. 
Immunocytochemical analysis of the effects of MPR on NMDA-induced trafficking of cell 
surface GluA1. Cultured hippocampal neurons expressing EGFP and HA-tagged wild type 
(GluA1wt) (A) or phospho-deficient GluA1 (GluA1AA) (C) or phosphomimetic GluA1 
(GluA1DD) (E) were treated with 50 µM NMDA for 10 min. Cell surface HA-GluA1 were 
stained (red) after fixation, and neurons were immunostained for total HA-GluA1 (blue) after 
treatment with Triton-X. The dendritic regions marked by squares were enlarged in the panels to 
the right. Scale bars, 10 µm. B, D, F. Quantification of NMDA-induced reduction in the ratio of 
the surface to total GluA1 fluorescence intensities with NMDA treatment. Data are represented 
as the ratio of surface HA-GluA1 immunoreactivity normalized by total HA-GluA1 
immunoreactivity. The ratio in control neurons was defined as 100% (n = 8‒14). Data are 
presented as mean + SEM and individual data points. **p < 0.01, *p < 0.05; n.s., not significant 
by two-tailed student’s t-test. 
 
Figure 5. Phosphomimetic mutations of MPR increased recycling of GluA1 to the cell surface. 
A. Schematic drawing of antibody feeding assay. Living neurons expressing HA-GluA1 mutants 
were labeled with an anti-HA antibody. After NMDA treatment, remaining cell surface 
antibodies were removed by acid treatment. After a 30 min incubation to allow the recycling of 
HA-GluA1, neurons were fixed and recycled, and internal HA-GluA1 was visualized by 
Alexa546- and Alexa350-conjugated secondary antibodies, respectively. B. 
Immunocytochemical analysis of the effects of the MPR phosphorylation on the recycling of 
GluA1 after NMDA treatment. Cultured living hippocampal neurons expressing HA-GluA1wt or 
HA-GluA1AA or HA-GluA1DD were subjected to the antibody feeding assay. The dendritic 
regions marked by white squares are enlarged in the panels to the right. Scale bars, 10 µm. C. 
Quantification of the recycled GluA1. Data are represented as the ratio of recycled HA-GluA1 
staining/total HA-GluA1 staining intensity. The ratio of HA-GluA1wt was defined as 100% (n = 
12 cells). Data are presented as mean + SEM and individual data points. **P < 0.01, *p < 0.05 
by one-way ANOVA and Student-Newman-Keuls post hoc test. 
 
Figure 6. Phosphomimetic mutations of MPR inhibit the transport of GluA1 to late endosomes 
and lysosomes. A. Colocalization of HA-tagged mutant GluA1 with an early endosome marker, 
EGFP-tagged Rab4 at 0 min, and 3 min after NMDA treatment. Scale bar, 10 µm. B. 
Colocalization of HA-tagged mutant GluA1 with a late endosome/lysosome marker, EGFP-
tagged Rab7 at 0 min, and 10 min after NMDA treatment. C, D. Quantification of the 
colocalization of HA-tagged wild type or mutant GluA1 with Rab proteins. Data are represented 
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as the ratio of colocalized HA-GluA1 staining/total HA-GluA1 staining intensity. The ratio in 
the neurons without NMDA stimulation (0 min) was defined as 100% (n = 9-12 cells). Data are 
presented as mean + SEM and individual data points. **p < 0.01, *p < 0.05 n.s. not significant 
by Kruskal-Wallis test and Steel-Dwass post hoc test. 
 
Figure 7. Phosphorylation of GluA1 MPR, Seri831, and Ser845. A. Phosphorylation of GluA1 
MPR by NMDA stimulation. Cultured hippocampal neurons were treated with 50 µM NMDA 
for 10 min and immunoprecipitated using the anti-4.1N antibody after solubilization. The 
amount of immunoprecipitated 4.1N and co-immunoprecipitated GluA1 were analyzed by 
immunoblot analysis. The intensities of the bands corresponding to GluA1 (top) and 4.1N 
(bottom) in the immunoprecipitated (IPed) fraction were normalized to the intensity of the 
respective molecule in the input fraction. Data are presented as mean + SEM and individual data 
points (Mann-Whitney U test, **p < 0.01; n.s., not significant; n = 5‒6). B. Ser831 
phosphorylation by CaMKII was not affected by mutations in the MPR. GST fusion proteins 
with C-termini of GluA1wt (GluA1CTwt), GluA1AA (GluA1CTAA), and GluA1DD (GluA1CTDD) 
were phosphorylated by CaMKII in vitro and analyzed by the immunoblot analysis using anti-
phospho-Ser831 GluA1 (top) and anti-GST (botto) antibodies. Data are presented as mean + 
SEM and individual data points (Kruskal-Wallis test; n.s., not significant; n = 5). C. Ser845 
phosphorylation by PKA was not affected by mutations in the MPR. GluA1CTwt, GluA1CTAA, 
and GluA1CTDD were phosphorylated in vitro by PKA and analyzed by immunoblot analysis 
using anti-phosphor-Ser845 GluA1 and anti-GST antibodies. Data are presented as mean + 
SEM and individual data points (Kruskal-Wallis test; n.s., not significant; n = 5). 
 
Figure 8. MPR regulates NMDA-induced trafficking of heteromeric AMPA receptors. A, B, C. 
Immunocytochemical analysis of the effects of MPR on NMDA-induced trafficking of cell 
surface heteromeric AMPA receptors. Cultured hippocampal neurons expressing wild-type HA- 
GluA2 together with GluA1wt (A), GluA1AA (B) or GluA1DD (C) were treated with 50 µM NMDA 
for 10 min and stained for surface HA-GluA2 (red). After Triton X treatment, neurons were 
stained for total HA-GluA2 (blue). The dendritic regions marked by white squares were enlarged 
in the panels to the right. Scale bars, 10 µm. D, E, F. The graphs represent the quantification of 
NMDA-induced reduction in the amount of cell surface HA-GluA2 in the presence of GluA1wt or 
GluA1AA or GluA1DD. Data are represented as the ratio of surface HA-GluA2 staining/total HA-
GluA2 staining intensity. The ratio in control neurons was defined as 100% (n = 11-19 cells). Data 
are presented as mean + SEM and individual data points. **p < 0.01, *p < 0.05 n.s., not significant 
by two-tailed student’s t-test. 
 
Figure 9. A model for AMPAR trafficking during LTD achieved by a cross-talk between subunit-
dependent and independent mechanisms. An auxiliary AMPAR subunit, STG, stabilizes 
postsynaptic AMPARs by binding to anchoring proteins, such as PSD95. LTD-inducing stimuli 
dephosphorylates the C-terminus of STG and triggers lateral diffusion of the AMPAR-STG 
complex by reducing the binding affinity of STG to PSD-95. At the endocytic zone, 
dephosphorylated STG binds to AP-2 to initiate clathrin-dependent endocytosis of the AMPAR-
STG complex. In the early endosomes, AP-2 is eventually replaced with AP-3 to facilitate late 
endosomal/lysosomal trafficking of the AMPAR-STG complex to express LTD (A). In contrast, 
AMPARs containing GluA1 behave differently depending on the phosphorylation status of the 
MPR, which only occurs in the GluA1 subunit. When the MPR of GluA1 remains phosphorylated, 
AP-3 cannot be effectively recruited to the AMPAR-STG complex. Such AMPARs are transported 
back to the cell surface, resulting in impaired LTD (B). 
 









